Internal Reference Number: FOI_8513
Date Request Received: 12/03/2025 00:00:00
Date Request Replied To: 01/04/2025 00:00:00
This response was sent via: By Email
Request Summary: Request on HAE and IG
Request Category: Researcher
Question Number 1: I have a freedom of information request I would appreciate your assistance with, can you please answer the following In the past 3 months, how many patients have received the following treatments (for any disease): • Berinert (Human C1-esterase inhibitor) • Cinryze (Human C1-esterase inhibitor) • Firazyr (Icatibant) • Icatibant - any brand except Firazyr • Orladeyo (Berotralstat) • Ruconest (Recombinant human C1-esterase inhibitor) • Takhzyro (Lanadelumab) • Garadacimab (Andembry) | |
Answer To Question 1: Zero for all products | |
Question Number 2: Q2. In the past 3 months how many patients have received the following immunoglobulin treatments (for any disease): • Cutaquig • Cuvitru • Gammagard • Gammanorm • Hizentra • Hyqvia • Intratect • Iqymune • Kiovig • Privigen • Octagam • Panzyga • Subgam • Any other normal immunoglobulin | |
Answer To Question 2: Privigen 29 patients Iqymune 7 patients Intratect 10 patients Octagam <5 patients Any other normal immunoglobulin (Gamunex) <5 patients 0 patients received any of the other products listed | |
To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.